Abnormal cortical responses to somatosensory stimulation in medication-overuse headache

BMC Neurology

Volumn 10, Issue , 2010, Pages

  Coppola, Gianluca ^a   Currà, Antonio ^b   Di Lorenzo, Cherubino ^c,d   Parisi, Vincenzo ^a   Gorini, Manuela ^b   Sava, Simona L ^d   Schoenen, Jean ^d   Pierelli, Francesco ^b,e  

^a IRCCS FONDAZIONE BIETTI   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

^d UNIVERSITY OF LIÈGE   (Belgium)

^e IRCCS NEUROMED   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT; TRIPTAN DERIVATIVE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DRUG INDUCED HEADACHE; DRUG OVERDOSE; EVOKED CORTICAL RESPONSE; EVOKED SOMATOSENSORY RESPONSE; FEMALE; HABITUATION; HEADACHE; HUMAN; MALE; MIGRAINE; MIGRAINE WITHOUT AURA; SOMATOSENSORY STIMULATION; ANALYSIS OF VARIANCE; CHEMICALLY INDUCED DISORDER; ELECTROSTIMULATION; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; SECONDARY HEADACHE; SOMATOSENSORY CORTEX;

ADULT; ANALYSIS OF VARIANCE; ELECTRIC STIMULATION; EVOKED POTENTIALS, SOMATOSENSORY; FEMALE; HEADACHE DISORDERS, SECONDARY; HUMANS; MALE; MIDDLE AGED; SOMATOSENSORY CORTEX;

EID: 78650624166     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-10-126     Document Type: Article

References (46)

1. Olesen J, Bousser MG, Diener HC, Dodick D, First M, Goadsby PJ, Göbel H, Lainez MJA, Lance JW, Lipton RB, Nappi G, Sakai F, Schoenen J, Silberstein SD, Steiner TJ. Headache Classification Committee New appendix criteria open for a broader concept of chronic migraine. Cephalalgia 2006, 26(6):742-746. 10.1111/j.1468-2982.2006.01172.x, 16686915, Headache Classification Committee.
2. Stovner LJ, Zwart JA, Hagen K, Terwindt GM, Pascual J. Epidemiology of headache in Europe. Eur J Neurol 2006, 13(4):333-345. 10.1111/j.1468-1331.2006.01184.x, 16643310.
3. Silberstein SD, Olesen J, Bousser MG, Diener HC, Dodick D, First M, Goadsby PJ, Göbel H, Lainez MJA, Lance JW, Lipton RB, Nappi G, Sakai F, Schoenen J, Steiner TJ, . International Headache Society The International Classification of Headache Disorders, 2nd Edition (ICHD-II)--revision of criteria for 8.2 Medication-overuse headache. Cephalalgia 2005, 25(6):460-465. 10.1111/j.1468-2982.2005.00878.x, 15910572, International Headache Society.
4. Calabresi P, Cupini LM. Medication-overuse headache: similarities with drug addiction. Trends Pharmacol Sci 2005, 26(2):62-68. 10.1016/j.tips.2004.12.008, 15681022.
5. Fumal A, Laureys S, Di Clemente L, Boly M, Bohotin V, Vandenheede M, Coppola G, Salmon E, Kupers R, Schoenen J. Orbitofrontal cortex involvement in chronic analgesic-overuse headache evolving from episodic migraine. Brain 2006, 129(Pt 2):543-550.
6. Schoenen J. Deficient habituation of evoked cortical potentials in migraine: a link between brain biology, behavior and trigeminovascular activation?. Biomed Pharmacother 1996, 50(2):71-78. 10.1016/0753-3322(96)84716-0, 8761712.
7. Aurora SK, Wilkinson F. The brain is hyperexcitable in migraine. Cephalalgia 2007, 27(12):1442-1453. 10.1111/j.1468-2982.2007.01502.x, 18034688.
8. Coppola G, Pierelli F, Schoenen J. Is the cerebral cortex hyperexcitable or hyperresponsive in migraine?. Cephalalgia 2007, 27(12):1427-1439. 10.1111/j.1468-2982.2007.01500.x, 18034686.
9. Evers S, Quibeldey F, Grotemeyer KH, Suhr B, Husstedt IW. Dynamic changes of cognitive habituation and serotonin metabolism during the migraine interval. Cephalalgia 1999, 19(5):485-491. 10.1046/j.1468-2982.1999.019005485.x, 10403063.
10. Kropp P, Gerber WD. Prediction of migraine attacks using a slow cortical potential, the contingent negative variation. Neurosci Lett 1998, 257(2):73-76. 10.1016/S0304-3940(98)00811-8, 9865930.
11. Siniatchkin M, Kropp P, Gerber WD, Stephani U. Migraine in childhood--are periodically occurring migraine attacks related to dynamic changes of cortical information processing?. Neurosci Lett 2000, 279(1):1-4. 10.1016/S0304-3940(99)00924-6, 10670773.
12. Kropp P, Gerber WD. Contingent negative variation during migraine attack and interval: evidence for normalization of slow cortical potentials during the attack. Cephalalgia 1995, 15(2):123-128. 10.1046/j.1468-2982.1995.015002123.x, 7641246.
13. Judit A, Sándor PS, Schoenen J. Habituation of visual and intensity dependence of auditory evoked cortical potentials tends to normalize just before and during the migraine attack. Cephalalgia 2000, 20(8):714-719.
14. Chen WT, Wang SJ, Fuh JL, Lin CP, Ko YC, Lin YY. Peri-ictal normalization of visual cortex excitability in migraine: an MEG study. Cephalalgia 2009, 29(11):1202-1211. 10.1111/j.1468-2982.2009.01857.x, 19558536.
15. Groves PM, Thompson RF. Habituation: a dual-process theory. Psychol Rev 1970, 77(5):419-450. 10.1037/h0029810, 4319167.
16. Rankin CH, Abrams T, Barry RJ, Bhatnagar S, Clayton DF, Colombo J, Coppola G, Geyer MA, Glanzman DL, Marsland S, McSweeney FK, Wilson DA, Wu CF, Thompson RF. Habituation revisited: an updated and revised description of the behavioral characteristics of habituation. Neurobiol Learn Mem 2009, 92(2):135-138. 10.1016/j.nlm.2008.09.012, 2754195, 18854219.
17. Ozkul Y, Uckardes A. Median nerve somatosensory evoked potentials in migraine. Eur J Neurol 2002, 9(3):227-232. 10.1046/j.1468-1331.2002.00387.x, 11985630.
18. Cruccu G, Aminoff MJ, Curio G, Guerit JM, Kakigi R, Mauguiere F, Rossini PM, Treede RD, Garcia-Larrea L. Recommendations for the clinical use of somatosensory-evoked potentials. Clin Neurophysiol 2008, 119(8):1705-1719. 10.1016/j.clinph.2008.03.016, 18486546.
19. Schmidt-Wilcke T, Leinisch E, Straube A, Kämpfe N, Draganski B, Diener HC, Bogdahn U, May A. Gray matter decrease in patients with chronic tension type headache. Neurology 2005, 65(9):1483-1486. 10.1212/01.wnl.0000183067.94400.80, 16275843.
20. Woolf CJ, Wall PD. Relative effectiveness of C primary afferent fibers of different origins in evoking a prolonged facilitation of the flexor reflex in the rat. J Neurosci 1986, 6(5):1433-1442.
21. Lebrun P, Manil J, Colin F. Formalin-induced central sensitization in the rat: somatosensory evoked potential data. Neurosci Lett 2000, 283(2):113-116. 10.1016/S0304-3940(00)00934-4, 10739888.
22. Baron R, Baron Y, Disbrow E, Roberts TP. Activation of the somatosensory cortex during Abeta-fiber mediated hyperalgesia. A MSI study. Brain Res 2000, 871(1):75-82. 10.1016/S0006-8993(00)02444-6, 10882785.
23. Burstein R, Cutrer MF, Yarnitsky D. The development of cutaneous allodynia during a migraine attack clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine. Brain 2000, 123(Pt 8):1703-1709. 10.1093/brain/123.8.1703, 10908199.
24. Schoenen J, Bottin D, Hardy F, Gerard P. Cephalic and extracephalic pressure pain thresholds in chronic tension-type headache. Pain 1991, 47(2):145-149. 10.1016/0304-3959(91)90198-7, 1762808.
25. Lovati C, D'Amico D, Bertora P, Rosa S, Suardelli M, Mailland E, Mariani C, Bussone G. Acute and interictal allodynia in patients with different headache forms: an Italian pilot study. Headache 2008, 48(2):272-277. 10.1111/j.1526-4610.2007.00998.x, 18081821.
26. Sandrini G, Rossi P, Milanov I, Serrao M, Cecchini AP, Nappi G. Abnormal modulatory influence of diffuse noxious inhibitory controls in migraine and chronic tension-type headache patients. Cephalalgia 2006, 26(7):782-789. 10.1111/j.1468-2982.2006.01130.x, 16776692.
27. Kaube H, Katsarava Z, Przywara S, Drepper J, Ellrich J, Diener HC. Acute migraine headache: possible sensitization of neurons in the spinal trigeminal nucleus?. Neurology 2002, 58(8):1234-1238.
28. Ayzenberg I, Obermann M, Nyhuis P, Gastpar M, Limmroth V, Diener HC, Kaube H, Katsarava Z. Central sensitization of the trigeminal and somatic nociceptive systems in medication overuse headache mainly involves cerebral supraspinal structures. Cephalalgia 2006, 26(9):1106-1114. 10.1111/j.1468-2982.2006.01183.x, 16919061.
29. Hsueh SF, Lu CY, Chao CS, Tan PH, Huang YW, Hsieh SW, Hsiao HT, Chung NC, Lin SH, Huang PL, Lyu PC, Yang LC. Nonsteroidal anti-inflammatory drugs increase expression of inducible COX-2 isoform of cyclooxygenase in spinal cord of rats with adjuvant induced inflammation. Brain Res Mol Brain Res 2004, 125(1-2):113-119. 10.1016/j.molbrainres.2004.03.016, 15193428.
30. Seybold VS, Jia YP, Abrahams LG. Cyclo-oxygenase-2 contributes to central sensitization in rats with peripheral inflammation. Pain 2003, 105(1-2):47-55. 10.1016/S0304-3959(03)00254-9, 14499419.
31. Ferrari MD, Saxena PR. On serotonin and migraine: a clinical and pharmacological review. Cephalalgia 1993, 13(3):151-165. 10.1046/j.1468-2982.1993.1303151.x, 8395342.
32. Sakai Y, Dobson C, Diksic M, Aubé M, Hamel E. Sumatriptan normalizes the migraine attack-related increase in brain serotonin synthesis. Neurology 2008, 70(6):431-439. 10.1212/01.wnl.0000299095.65331.6f, 18250288.
33. Dobson CF, Tohyama Y, Diksic M, Hamel E. Effects of acute or chronic administration of anti-migraine drugs sumatriptan and zolmitriptan on serotonin synthesis in the rat brain. Cephalalgia 2004, 24(1):2-11. 10.1111/j.1468-2982.2004.00647.x, 14687006.
34. Srikiatkhachorn A, Tarasub N, Govitrapong P. Effect of chronic analgesic exposure on the central serotonin system: a possible mechanism of analgesic abuse headache. Headache 2000, 40(5):343-350. 10.1046/j.1526-4610.2000.00052.x, 10849027.
35. Ayzenberg I, Obermann M, Oberman M, Leineweber K, Franke L, Yoon MS, Diener HC, Katsarava Z. Increased activity of serotonin uptake in platelets in medication overuse headache following regular intake of analgesics and triptans. J Headache Pain 2008, 9(2):109-112. 10.1007/s10194-008-0019-9, 18330504.
36. Hering R, Glover V, Pattichis K, Catarci T, Steiner TJ. 5HT in migraine patients with medication-induced headache. Cephalalgia 1993, 13(6):410-412. 10.1046/j.1468-2982.1993.1306410.x, 8313455.
37. Krasne F, Edwards D. Modulation of the crayfish escape reflex - physiology and neuroethology. Integ Comp Biol 2002, 42:705-715.
38. Katsarava Z, Fritsche G, Muessig M, Diener HC, Limmroth V. Clinical features of withdrawal headache following overuse of triptans and other headache drugs. Neurology 2001, 57(9):1694-1698.
39. Knott JR, Irwin DA. Anxiety, stress, and the contingent negative variation. Arch Gen Psychiatry 1973, 29(4):538-541.
40. Nestler EJ. Common molecular and cellular substrates of addiction and memory. Neurobiol Learn Mem 2002, 78(3):637-647. 10.1006/nlme.2002.4084, 12559841.
41. Tassin JP. Uncoupling between noradrenergic and serotonergic neurons as a molecular basis of stable changes in behavior induced by repeated drugs of abuse. Biochem Pharmacol 2008, 75(1):85-97. 10.1016/j.bcp.2007.06.038, 17686465.
42. Hyman SE, Malenka RC, Nestler EJ. Neural mechanisms of addiction: the role of reward-related learning and memory. Annu Rev Neurosci 2006, 29:565-598. 10.1146/annurev.neuro.29.051605.113009, 16776597.
43. Radat F, Creac'h C, Guegan-Massardier E, Mick G, Guy N, Fabre N, Giraud P, Nachit-Ouinekh F, Lantéri-Minet M. Behavioral dependence in patients with medication overuse headache: a cross-sectional study in consulting patients using the DSM-IV criteria. Headache 2008, 48(7):1026-1036. 10.1111/j.1526-4610.2007.00999.x, 18081820.
44. Schoenbaum G, Shaham Y. The role of orbitofrontal cortex in drug addiction: a review of preclinical studies. Biol Psychiatry 2008, 63(3):256-262. 10.1016/j.biopsych.2007.06.003, 2246020, 17719014.
45. Petrides M. The orbitofrontal cortex: novelty, deviation from expectation, and memory. Ann N Y Acad Sci 2007, 1121:33-53. 10.1196/annals.1401.035, 17872393.
46. Rule RR, Shimamura AP, Knight RT. Orbitofrontal cortex and dynamic filtering of emotional stimuli. Cogn Affect Behav Neurosci 2002, 2(3):264-270. 10.3758/CABN.2.3.264, 12775190.